ETS, headquartered in Rolla, Missouri, USA, specializes in developing medical products utilizing proprietary borate-based bioactive glass. Our fl agship product, Mirragen®, represents a breakthrough in wound care technology as the fi rst FDA-cleared inorganic bioactive glass-based solution. Mirragen® is a borate-based bioactive glass fi ber matrix that facilitates quality tissue formation, without the risk of infection that tissue-based products have, all in an easy to use, versatile form factor.